Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives.

Auteurs : Caparica R, Lambertini M, Pondé N, Fumagalli D, de Azambuja E, Piccart-Gebhart M
Jaar : 2019
Journal : Ther Adv Med Oncol
Volume : 11
Pagina's : 1758835919827714

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.

Auteurs : Morschhauser F, Machiels JP, Salles G, Rottey S, Rule SA, Cunningham D, Peyrade F, Fruchart C, Arkenau HT, Genvresse I, Liu L, Köchert K, Shen K, Kneip C, Peña CE, Grevel J, Zhang J, Cisternas G, Reschke S, Granvil C, Awada A
Jaar : 2019
Journal : Mol Cancer Ther

Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.

Auteurs : Caparica R, Bruzzone M, Poggio F, Ceppi M, de Azambuja E, Lambertini M
Jaar : 2019
Journal : Breast Cancer Res Treat
Volume : 174
Pagina's : 27-37

Targeted therapy for breast cancer in older patients.

Auteurs : Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Lago LD
Jaar : 2019
Journal : J Geriatr Oncol

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Auteurs : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Jaar : 2019
Journal : J Nucl Med
Volume : 60
Pagina's : 178-184

Differentiated-Type Intraepithelial Neoplasia-Like Lesion Associated with Squamous Cell Carcinoma of the Anus: A Case Report with Molecular Profile.

Auteurs : Koopmansch C, Maris C, Demetter P, Van de Stadt J, Hendlisz A, DHaene N, Noël JC
Jaar : 2019
Journal : Case Rep Pathol
Volume : 2019
Pagina's : 2301640

Lucitanib for the treatment of HR<sup>+</sup>/ HER2<sup>-</sup> metastatic breast cancer: results from the multicohort phase II FINESSE study.

Auteurs : Hui R, Pearson A, Cortés J, Campbell C, Poirot C, Azim HA, Fumagalli D, Lambertini M, Daly F, Arahmani A, Pérez-Garcia J, Aftimos P, Bedard PL, Xuereb L, Scheepers ED, Vicente M, Goulioti T, Loibl S, Loi S, Pierrat MJ, Turner NC, Andre F, Curigliano G
Jaar : 2019
Journal : Clin Cancer Res

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.

Auteurs : Ruhstaller T, Giobbie-Hurder A, Colleoni M, Jensen MB, Ejlertsen B, de Azambuja E, Neven P, Láng I, Jakobsen EH, Gladieff L, Bonnefoi H, Harvey VJ, Spazzapan S, Tondini C, Del Mastro L, Veyret C, Simoncini E, Gianni L, Rochlitz C, Kralidis E, Zaman K, Jassem J, Piccart-Gebhart M, Di Leo A, Gelber Rd, Coates AS, Goldhirsch A, Thürlimann B, Regan MM
Jaar : 2019
Journal : J Clin Oncol
Volume : 37
Pagina's : 105-114

Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

Auteurs : Diéras V, Bonnefoi H, Alba E, Awada A, Coudert B, Pivot X, Gligorov J, Jager A, Zambelli S, Lindeman GJ, Charpentier E, Emmons GT, Garcia-Ribas I, Paridaens R, Verweij J
Jaar : 2019
Journal : Breast Cancer Res Treat
Volume : 177
Pagina's : 383-393

ESR1 mutations in metastatic lobular breast cancer patients.

Auteurs : Desmedt C, Pingitore J, Rothé F, Marchio C, Clatot F, Rouas G, Richard F, Bertucci F, Mariani O, Galant C, Fribbens C, OLeary B, Van den Eynden G, Salgado R, Turner NC, Piccart-Gebhart M, Vincent-Salomon A, Pruneri G, Larsimont D, Sotiriou C
Jaar : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pagina's : 9

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

Auteurs : de Azambuja E, Ponde N, Procter M, Rastogi P, Cecchini RS, Lambertini M, Ballman K, Aspitia AM, Zardavas D, Roca L, Gelber Rd, Piccart-Gebhart M, Suter T
Jaar : 2019
Journal : Breast Cancer Res Treat

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

Auteurs : Adams S, Schmid P, Rugo HS, Winer EP, Loirat D, Awada A, Cescon DW, Iwata H, Campone M, Nanda R, Hui R, Curigliano G, Toppmeyer D, OShaughnessy J, Loi S, Paluch-Shimon S, Tan AR, Card D, Zhao J, Karantza V, Cortés J
Jaar : 2019
Journal : Ann Oncol
Volume : 30
Pagina's : 397-404

Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications.

Auteurs : Martens S, Lefesvre P, Nicolle R, Biankin AV, Puleo F, Van Laethem JL, Rooman I
Jaar : 2019
Journal : Ann Oncol
Volume : 30
Pagina's : 1428-1436

<sup>68</sup>Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy.

Auteurs : Artigas C, Flamen P, Charlier F, Levillain H, Wimana Z, Diamand R, Albisinni S, Gil T, Velthoven Rv, Peltier A, Gestel DV, Roumeguere T, Otte FX
Jaar : 2019
Journal : World J Urol
Volume : 37
Pagina's : 1535-1542

Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.

Auteurs : Lucidi V, Bohlok A, Liberale G, Bez M, Germanova D, Bouazza F, Demetter P, Larsimont D, Aftimos P, Smoll NR, Donckier V
Jaar : 2019
Journal : Eur J Surg Oncol

How I treat metastatic triple-negative breast cancer.

Auteurs : Caparica R, Lambertini M, de Azambuja E
Jaar : 2019
Journal : ESMO Open
Volume : 4
Pagina's : e000504

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an 'option' but an ethical obligation.

Auteurs : Brandão M, Reyal F, Hamy AS, Piccart-Gebhart M
Jaar : 2019
Journal : ESMO Open
Volume : 4
Pagina's : e000515

Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Auteurs : Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P
Jaar : 2019
Journal : J Nucl Med
Volume : 60
Pagina's : 1366-1372

Post-Mastectomy Radiation Therapy in HER-2 Positive Breast Cancer Patients: Analysis of the HERA Trial.

Auteurs : Jaoude JA, de Azambuja E, Makki M, Tamim H, Tfayli A, Geara F, Piccart-Gebhart M, Poortmans P, Zeidan YH
Jaar : 2019
Journal : Int J Radiat Oncol Biol Phys

Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report.

Auteurs : Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A
Jaar : 2019
Journal : Rev Med Interne
Volume : 40
Pagina's : 258-261